CBNT Stock Overview
C-Bond Systems, Inc., a nanotechnology company, owns, develops, manufactures, and sells patented C-Bond technology in the United Sates.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
C-Bond Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0042 |
| 52 Week High | US$0.015 |
| 52 Week Low | US$0.003 |
| Beta | 0.76 |
| 1 Month Change | -2.33% |
| 3 Month Change | -14.63% |
| 1 Year Change | -8.70% |
| 3 Year Change | -83.53% |
| 5 Year Change | -97.18% |
| Change since IPO | -99.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| CBNT | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | 1.2% |
| 1Y | -8.7% | 8.9% | 24.7% |
Return vs Industry: CBNT underperformed the US Chemicals industry which returned 6.4% over the past year.
Return vs Market: CBNT underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| CBNT volatility | |
|---|---|
| CBNT Average Weekly Movement | 14.7% |
| Chemicals Industry Average Movement | 5.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CBNT's share price has been volatile over the past 3 months.
Volatility Over Time: CBNT's weekly volatility has decreased from 23% to 15% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 20 | Scott Silverman | www.cbondsystems.com |
C-Bond Systems, Inc., a nanotechnology company, owns, develops, manufactures, and sells patented C-Bond technology in the United Sates. The company’s products include C-Bond NanoShield, a patented nanotechnology windshield glass strengthening and hydrophobic performance system to enhance windshield safety and performance; C-Bond Secure, a patented non-toxic water-based nanotechnology solution to increase the strength of architectural glass and performance properties of window film-to-glass products; and C-Bond BRS, a patented nanotechnology ballistic-resistant film system that increases the structural integrity of glass. It also distributes MB-10 and Vimoba disinfectant tablets to Automotive, Trucking, RV, rental agencies, service vehicles, mass transit, golf carts, aviation, train, and marine markets, as well as to transportation dealerships, and service providers.
C-Bond Systems, Inc. Fundamentals Summary
| CBNT fundamental statistics | |
|---|---|
| Market cap | US$2.26m |
| Earnings (TTM) | US$1.84m |
| Revenue (TTM) | US$2.49m |
1.2x
P/E Ratio0.9x
P/S RatioIs CBNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBNT income statement (TTM) | |
|---|---|
| Revenue | US$2.49m |
| Cost of Revenue | US$1.18m |
| Gross Profit | US$1.31m |
| Other Expenses | -US$533.96k |
| Earnings | US$1.84m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0034 |
| Gross Margin | 52.54% |
| Net Profit Margin | 74.00% |
| Debt/Equity Ratio | -81.5% |
How did CBNT perform over the long term?
See historical performance and comparison